A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress.
Mor HananAlon SimchovitzNadav YayonShani VaknineRoni Cohen-FultheimMiriam KarmonNimrod MadrerTalia Miriam RohrlichMoria MamanEstelle R BennettDavid S GreenbergEran MeshorerErez Y LevanonHermona SoreqSebastian KadenerPublished in: EMBO molecular medicine (2020)
Circular RNAs (circRNAs) are brain-abundant RNAs of mostly unknown functions. To seek their roles in Parkinson's disease (PD), we generated an RNA sequencing resource of several brain region tissues from dozens of PD and control donors. In the healthy substantia nigra (SN), circRNAs accumulate in an age-dependent manner, but in the PD SN this correlation is lost and the total number of circRNAs reduced. In contrast, the levels of circRNAs are increased in the other studied brain regions of PD patients. We also found circSLC8A1 to increase in the SN of PD individuals. CircSLC8A1 carries 7 binding sites for miR-128 and is strongly bound to the microRNA effector protein Ago2. Indeed, RNA targets of miR-128 are also increased in PD individuals, suggesting that circSLC8A1 regulates miR-128 function and/or activity. CircSLC8A1 levels also increased in cultured cells exposed to the oxidative stress-inducing agent paraquat but were decreased in cells treated with the neuroprotective antioxidant regulator drug Simvastatin. Together, our work links circSLC8A1 to oxidative stress-related Parkinsonism and suggests further exploration of its molecular function in PD.
Keyphrases
- oxidative stress
- induced apoptosis
- cell proliferation
- long non coding rna
- dna damage
- white matter
- end stage renal disease
- resting state
- gene expression
- newly diagnosed
- cell cycle arrest
- signaling pathway
- magnetic resonance
- chronic kidney disease
- ischemia reperfusion injury
- single cell
- emergency department
- functional connectivity
- prognostic factors
- regulatory t cells
- parkinson disease
- endothelial cells
- peritoneal dialysis
- dendritic cells
- drug induced
- kidney transplantation
- adverse drug
- nucleic acid